BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25724739)

  • 1. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis.
    Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J
    Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are we facing a potential effective treatment for endometriosis?
    Nezhat CR; Balassiano E
    Fertil Steril; 2015 May; 103(5):1151. PubMed ID: 25813290
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen stabilizes hypoxia-inducible factor 1α through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis.
    Zhang L; Xiong W; Li N; Liu H; He H; Du Y; Zhang Z; Liu Y
    Fertil Steril; 2017 Feb; 107(2):439-447. PubMed ID: 27939762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells.
    Imesch P; Samartzis EP; Dedes KJ; Fink D; Fedier A
    Fertil Steril; 2013 Sep; 100(3):770-6. PubMed ID: 23755949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER.
    Gui Y; Shi Z; Wang Z; Li JJ; Xu C; Tian R; Song X; Walsh MP; Li D; Gao J; Zheng XL
    J Cell Physiol; 2015 Apr; 230(4):885-95. PubMed ID: 25204801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
    Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
    Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
    Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
    Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
    Long L; Cao Y; Tang LD
    Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model.
    Takai E; Taniguchi F; Nakamura K; Uegaki T; Iwabe T; Harada T
    Fertil Steril; 2013 Oct; 100(4):1170-8. PubMed ID: 23876538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
    Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
    Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arcyriaflavin a, a cyclin D1-cyclin-dependent kinase4 inhibitor, induces apoptosis and inhibits proliferation of human endometriotic stromal cells: a potential therapeutic agent in endometriosis.
    Hirakawa T; Nasu K; Aoyagi Y; Takebayashi K; Narahara H
    Reprod Biol Endocrinol; 2017 Jul; 15(1):53. PubMed ID: 28720098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
    Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein‑coupled estrogen receptor/miR‑148a/human leukocyte antigen‑G signaling pathway mediates cell apoptosis of ovarian endometriosis.
    He SZ; Li J; Bao HC; Wang MM; Wang XR; Huang X; Li FH; Zhang W; Xu AL; Fang HC; Sheng YX
    Mol Med Rep; 2018 Jul; 18(1):1141-1148. PubMed ID: 29845209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
    Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells.
    Hirakawa T; Nasu K; Abe W; Aoyagi Y; Okamoto M; Kai K; Takebayashi K; Narahara H
    Hum Reprod; 2016 Nov; 31(11):2587-2597. PubMed ID: 27619772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
    Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
    BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium.
    Plante BJ; Lessey BA; Taylor RN; Wang W; Bagchi MK; Yuan L; Scotchie J; Fritz MA; Young SL
    Reprod Sci; 2012 Jul; 19(7):684-93. PubMed ID: 22378861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.